Navigating a Path to Liquidity in Today’s Climate

Victoria represents life sciences, healthcare and technology clients in a range of strategic transactions, including mergers, reverse mergers and other going public M&A transactions, stock and asset acquisitions, carve-out transactions and divestitures, and strategic investments. She regularly advises public and private companies on both the buy-side and the sell-side, and her M&A experience includes a number of cross-border transactions involving companies based in the United Kingdom, Europe, Asia, the Middle East and Australia.

During law school, Victoria was note and comment editor for the Minnesota Journal of International Law and spent five weeks studying abroad in Shanghai, PRC, with Willamette College of Law.

Amanda is a recognized, focused and innovative leader in the capital markets and life sciences space.

She advises life sciences and technology companies with respect to corporate finance, SEC reporting and governance matters. Amanda has represented issuers and underwriters in a wide variety of public and private financing transactions, including initial public offerings, follow-on and secondary offerings, SPACs, at-the-market offerings, private investment in public equity (PIPEs), and preferred stock and debt financings.

Amanda also advises late-stage private companies with respect to general corporate governance and liquidity preparation and public companies on corporate and securities law compliance and disclosure matters, including corporate governance best practices, Exchange Act reporting obligations and stock exchange requirements.